StraightFrom® Whole Blood CD66b MicroBeads were developed for rapid positive selection of CD66b+ cells directly from human whole blood. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis.
Related products for StraightFrom® Whole Blood CD66b MicroBeads, human
StraightFrom® Whole Blood CD66b MicroBeads were developed for rapid positive selection of CD66b+ cells directly from human whole blood. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis.
StraightFrom® Whole Blood CD66b MicroBeads are developed for the positive selection of CD66b+ cells directly from anticoagulated whole blood by using the autoMACS® Pro Separator, the MultiMACS™ Cell24 Separator Plus, or the Whole Blood Column Kit. No sample preparation is required, including density gradient centrifugation or erythrocyte lysis. CD66b is a 95–100 kDa glycosylphosphatidylinositol (GPI)-linked protein also known as CD67, CGM6, and NCA-95. It is expressed on neutrophils and eosinophils but not on basophils and lymphocytes.
Anticoagulated whole blood samples of 0.25–15 mL are labeled with StraightFrom® Whole Blood CD66b MicroBeads to be subsequently separated with the autoMACS® Pro Separator, the MultiMACS™ Cell24 Separator Plus, or using the Whole Blood Column Kit.
autoMACS® Columns or Whole Blood Columns.
Separation of a whole blood sample using the StraightFrom® Whole Blood CD66b MicroBeads and the MultiMACS™ Cell24 Separator Plus with the Single-Column Adapter and Whole Blood Columns without washing step after labeling. Cells were fluorescently stained with CD15‑FITC, CD66b-PE, as well as CD45‑VioBlue® and analyzed by flow cytometry using the MACSQuant® Analyzer. Cells were triggered via CD45-VioBlue, cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide fluorescence.
You have previously chosen International as your location.
What do you want to do?